Nuwellis (NUWE) Accumulated Expenses (2011 - 2026)

Nuwellis (NUWE) posted Accumulated Expenses of $852000.0 for Q1 2026, up 85.22% on a QoQ basis from $460000.0 in Q4 2025, and up 23.66% year-over-year from $689000.0 in Q1 2025.

Nuwellis (NUWE) Accumulated Expenses (2011 - 2026) Analysis & Trends

Nuwellis' Accumulated Expenses history runs 16 years deep, the most recent figure standing at $852000.0 for Q1 2026.

  • Quarterly Accumulated Expenses rose 23.66% year-over-year to $852000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $852000.0 (up 23.66% YoY) and the FY2025 annual result came in at $460000.0, down 28.12% from the prior year.
  • Accumulated Expenses was $852000.0 for Q1 2026 at Nuwellis, up from $460000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $2.2 million in Q4 2022 and bottomed at $460000.0 in Q4 2025.
  • A 5-year average of $983823.5 and a median of $725000.0 in 2024 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses increased 29.87% — and 2023, when it sank 75.71%.
  • Nuwellis' Accumulated Expenses stood at $2.2 million in 2022, then sank by 75.71% to $525000.0 in 2023, then grew by 21.9% to $640000.0 in 2024, then retreated by 28.12% to $460000.0 in 2025, then jumped by 85.22% to $852000.0 in 2026.
  • Business Quant data shows NUWE's Accumulated Expenses at $852000.0 in Q1 2026, $460000.0 in Q4 2025, and $523000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 184.16 Bn 176.87 Bn 6.27 Bn
2 Stryker 128.86 Bn 125.98 Bn 3.81 Bn
3 Medtronic 108.89 Bn 99.67 Bn 6.41 Bn
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn
5 Edwards Lifesciences 47.44 Bn 43.76 Bn 1.29 Bn
6 GE HealthCare Technologies 28.45 Bn 26.16 Bn 1.98 Bn
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn
10 Nuwellis 118,483.07 -1.96 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 852,000.00
Dec 31, 2025 460,000.00
Sep 30, 2025 523,000.00
Jun 30, 2025 561,000.00
Mar 31, 2025 689,000.00
Dec 31, 2024 640,000.00
Sep 30, 2024 597,000.00
Jun 30, 2024 706,000.00
Mar 31, 2024 725,000.00
Dec 31, 2023 525,000.00
Sep 30, 2023 1.02 Mn
Jun 30, 2023 1.23 Mn
Mar 31, 2023 1.31 Mn
Dec 31, 2022 2.16 Mn
Sep 30, 2022 1.75 Mn
Jun 30, 2022 1.63 Mn
Mar 31, 2022 1.34 Mn
Dec 31, 2021 1.66 Mn
Sep 30, 2021 1.77 Mn
Jun 30, 2021 1.58 Mn